What did we learn from the SHIVA Trial and how might the

What did we learn from the SHIVA Trial and how might the "disappointing" results of this trial have been misinterpreted, thereby underestimating the potential benefits of targeted therapy?

What did we learn from the SHIVA Trial and in what ways might the “disappointing” results of this trial have been misinterpreted, thereby underestimating the potential benefits of targeted therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Dr. Wong Seng Weng, MBBS, MRCP(UK), FAMS (Medical Oncology)

Dr. Wong Seng Weng, MBBS, MRCP(UK), FAMS (Medical Oncology)

Medical Director & Consultant Medical Oncologist
The Cancer Centre (Singapore Medical Group)
Paragon Medical & Mt Elizabeth Novena
Specialist Centre Visiting Consultant
Mt Elizabeth Hospital & Mt Elizabeth Novena Hospital